Iodine ( DrugBank: Iodine )


2 diseases
IDDisease name (Link within this page)Number of trials
46Malignant rheumatoid arthritis1
88Chronic thromboembolic pulmonary hypertension1

46. Malignant rheumatoid arthritis


Clinical trials : 4,325 Drugs : 2,671 - (DrugBank : 417) / Drug target genes : 187 - Drug target pathways : 224
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1JPRN-UMIN000033222
2012/07/0102/07/2018Clinical Results of Prophylactic Iodine-supported Primary TKA for Compromised Cases Osteoarthritis, Rheumatoid arthritis of knee jointprophylactic iodine-suported primaru TKAFukui General HospitalNULLComplete: follow-up complete50years-old90years-oldMale and Female30Not selectedJapan

88. Chronic thromboembolic pulmonary hypertension


Clinical trials : 159 Drugs : 118 - (DrugBank : 23) / Drug target genes : 13 - Drug target pathways : 53
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1NCT03806907
(ClinicalTrials.gov)
April 1, 201915/1/2019Iodine Subtraction Mapping in the Diagnosis of Chronic Pulmonary Thromboembolic DiseaseIodiNe Subtraction maPpIng in the Diagnosis of chRonic Pulmonary thromboEmbolic Disease (INSPIRE): An Observational Diagnostic StudyChronic Thromboembolic Pulmonary HypertensionRadiation: Computed tomography lung subtraction iodine mappingUniversity of SheffieldSheffield Teaching Hospitals NHS Foundation TrustNot yet recruiting18 Years90 YearsAll100NULL